+91 8744044044 / 8750295029
info@globalpharmanetwork.com
Global Pharma Network

Carfilzomib

Carfilzomib is used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous treatments for multiple myeloma.

Generic Version of Carfilzomib Medicine

Query Form

Please fill in the details about your
medicine requirement on this form.

Global Pharma Network

60/4, T&T House. Yusuf Sarai.
New Delhi:110016 India.

Phone number

+91 8744044044

Email

info@globalpharmanetwork.com

Carfilzomib is a targeted therapy, used to treat multiple myeloma.

Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. The U.S. Food and Drug Administration (FDA) approved it on 20 July 2012 for use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy (such as lenalidomide) and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Carfilzomib Price, Multiple Myeloma Treatment, Generic Carfilzomib sold under the brand name in India
Carfilzomib is used to treat Multiple Myeloma.

Details of Carfilzomib Medication

Carfilzomib

Global Pharma Network can help you to provide access of Carfilzomib medications sold under the brand name for Multiple Myeloma treatment by connecting Patients, Health Care Centers, Pharmacies and Retail Outlets with approved supplier, exporter and distributor of Generic drugs, innovator brands and biosimilar medicines from India. Call Mr. Tarun at +91 8744044044 for more details.

For Urgent Requirement "Carfilzomib" Medication

Call at +91 9891296838 / 9811747774 for Carfilzomib availability, Carfilzomib Price and Carfilzomib sold under the brand name. How to procure FDA approved Carfilzomib Drugs for treatment of Multiple Myeloma in India and overseas?

Global Pharma
Network

A Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of FDA approved Carfilzomib a targeted therapy drug sold under the brand name for treatment of Multiple Myeloma in India and overseas. We will help you in importing and exporting this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present. USA, UK, Russia, China, India, Nepal, Bhutan, Myanmar / Burma, Laos, Thailand, Cambodia, Hong Kong, Macau, Malaysia, Indonesia, Middle East, Japan, Philippines.

Disclaimer

The information on the website is obtained through many different sources and the accuracy should be confirmed prior to use. The content of this website is not intended to be instructional for medical diagnosis or treatment. Always consult with your physician or qualified health care provider on medical issues.